Walgreens Offers Moderna And J&J COVID-19 Vaccine Booster Shots Nationwide

Walgreens Offers Moderna And J&J COVID-19 Vaccine Booster Shots Nationwide

Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots Nationwide
Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots Nationwide
Retail Bum

Retail Bum

Retail Bum

Retail Bum

Share
Walgreens is now offering eligible individuals the opportunity to receive Moderna and Johnson & Johnson (J&J) COVID-19 vaccine booster shots in stores nationwide.

The rollout of the booster shots follows the Food and Drug Administration’s (FDA) emergency use authorization and new guidance from the Centers for Disease Control and Prevention (CDC). According to the new guidance, eligible populations may choose to receive a dose different from the one they received for their initial series.

“As new guidance regarding COVID-19 vaccines continues to emerge, our communities are relying on pharmacists for information, support and guidance more than ever. Walgreens pharmacy teams are available to answer questions and make it easy to understand eligibility requirements and access COVID-19 vaccine, whether it’s a first dose or booster shot,” said Rina Shah, group vice president pharmacy operations and services, Walgreens.

The rollout of the booster shots comes at a time when efforts are still being made to even out vaccination rates across the country. While the United States has more than enough vaccines for all eligible individuals, there is continued hesitancy around the need and safety of the vaccines, which has ultimately contributed to disparities, especially among Hispanic and Black adults that are at a higher risk.

“As we help millions of Americans get their booster shot, vaccine hesitancy is still a barrier in many communities of color,” said Dr. Kevin Ban, chief medical officer at Walgreens.

“As we have throughout the COVID-19 pandemic, Walgreens will remain focused on driving equitable access to COVID-19 vaccines with vaccine equity clinics and educational initiatives.”

In the last month alone, Walgreens administered nearly 60 percent of its COVID-19 vaccines to people of color through its ongoing equity efforts.

Eligibility requirements for Moderna and Pfizer-BioTech booster doses remain the same, with individuals needing to wait at least six months after they complete their initial mRNA COVID-19 primary vaccine series to receive their booster dose. In addition, for those who received the J&J primary dose, a single vaccine booster dose is recommended for individuals 18 and older at least two months after receiving their initial J&J primary vaccine dose.

In terms of mixing and matching, it is recommended that individuals receive the same product for their booster dose as they did for their primary series.

For booster eligibility information, visit Walgreens.com/covidvaccine.

MUST READS
Ryan Cohen Acquires Stake in Nordstrom

Ryan Cohen Acquires Stake in Nordstrom

Activist investor Ryan Cohen has asked Nordstrom to make changes to its board after acquiring a sizable stake in the company. Cohen, who is now one of the top-five non-family shareholders in Nordstrom, wants a targeted board refresh that can support cost-cutting efforts in light

Estée Lauder Expects Smaller Decline in Sales

Estée Lauder Expects Smaller Decline in Sales

Estée Lauder is expecting a smaller decline in annual sales than anticipated, thanks to resilient demand for its skincare and fragrance products. In the U.S., the company is benefitting from continued demand from wealthier consumers who are indulging in smaller purchases, such as fragrances and

SHEIN Appoints Chairman of SHEIN Latin America

SHEIN Appoints Chairman of SHEIN Latin America

Fast fashion brand SHEIN has appointed Marcelo Claure as the chairman of its Latin America division. In his new role, Claure is expected to oversee the company’s strategy and stakeholder affairs in Latin America while working closely with SHEIN’s management team. “We are thrilled to

No more posts to show, explore other topics: